Skip to main content

Table 2 Base case product characteristics. Simulated characteristics in parentheses

From: HIV prevention is not all about HIV – using a discrete choice experiment among women to model how the uptake and effectiveness of HIV prevention products may also rely on pregnancy and STI protection

Product HIV efficacy
(bounds used in uncertainty analysis – uniform distribution)
STI efficacy Contraceptive protection Frequency of use
Oral pre-exposure prophylaxis 61% (40–75%) N (Y) N (Y) Daily
Vaginal Ring 55% (31–71%) N (Y) N (Y) Monthly
Injectable ARVs 75% (55–90%) N (Y) N (Y) Every three months
Condom 85% (66–94%) Y Y Coital
No condom 0 N N Coital